The active ingredient in magic mushrooms, psilocybin, is remarkably effective at reducing feelings of anxiety, depression, and other forms of mental anguish in cancer patients, according to a pair of new studies.
The annual Global Drug Survey charts drug use patterns across the globe. Of particular interest this year are some stats revealing which countries are the most likely to produce "bad trips" for users of psychedelic drugs.
Scientists this week published a study that reveals what the human brain looks like under the influence of psilocybin, the hallucinogenic chemical found in magic mushrooms.
These mushrooms may not have any hallucinogenic properties, but they are psychedelic in their own right, emitting a yellow-green glow in the darkness. Seven new species of luminescent mushrooms give fungal enthusiasts new insight into mushrooms' glowing evolution.